Oak Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Hold |
4,771
| – | – | 0.14% | 70 |
|
|
2025
Q1 | $2.31M | Buy |
4,771
+200
| +4% | +$97K | 0.17% | 66 |
|
|
2024
Q4 | $1.84M | Sell |
4,571
-188
| -4% | -$75.7K | 0.13% | 80 |
|
|
2024
Q3 | $2.21M | Hold |
4,759
| – | – | 0.15% | 71 |
|
|
2024
Q2 | $2.23M | Sell |
4,759
-100
| -2% | -$46.9K | 0.15% | 71 |
|
|
2024
Q1 | $2.03M | Sell |
4,859
-1,998
| -29% | -$835K | 0.14% | 81 |
|
|
2023
Q4 | $2.79M | Sell |
6,857
-357
| -5% | -$145K | 0.21% | 62 |
|
|
2023
Q3 | $2.51M | Sell |
7,214
-220
| -3% | -$76.5K | 0.21% | 62 |
|
|
2023
Q2 | $2.62M | Sell |
7,434
-582
| -7% | -$205K | 0.21% | 66 |
|
|
2023
Q1 | $2.53M | Buy |
8,016
+1,088
| +16% | +$343K | 0.21% | 67 |
|
|
2022
Q4 | $2M | Buy |
6,928
+700
| +11% | +$202K | 0.17% | 86 |
|
|
2022
Q3 | $1.8M | Hold |
6,228
| – | – | 0.15% | 76 |
|
|
2022
Q2 | $1.76M | Hold |
6,228
| – | – | 0.14% | 80 |
|
|
2022
Q1 | $1.63M | Sell |
6,228
-178
| -3% | -$46.4K | 0.1% | 89 |
|
|
2021
Q4 | $1.41M | Sell |
6,406
-500
| -7% | -$110K | 0.07% | 98 |
|
|
2021
Q3 | $1.25M | Hold |
6,906
| – | – | 0.07% | 94 |
|
|
2021
Q2 | $1.39M | Sell |
6,906
-291
| -4% | -$58.7K | 0.08% | 91 |
|
|
2021
Q1 | $1.55M | Buy |
7,197
+147
| +2% | +$31.6K | 0.09% | 89 |
|
|
2020
Q4 | $1.67M | Sell |
7,050
-12,090
| -63% | -$2.86M | 0.1% | 88 |
|
|
2020
Q3 | $5.21M | Buy |
19,140
+60
| +0.3% | +$16.3K | 0.35% | 53 |
|
|
2020
Q2 | $5.54M | Buy |
+19,080
| New | +$5.54M | 0.37% | 53 |
|